Showing BioInteractions for Amlexanox (DB01025)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
Interacting Group | Interacting Drugs | |
---|---|---|
Amlexanox is a Interleukin-3 antagonist | ||
1 | Interleukin-3 inhibitors | Polaprezinc |
2 | Interleukin-3 binders | Zinc chloride, Zinc sulfate, unspecified form |
Interacting Group | Interacting Drugs | |
---|---|---|
Amlexanox is a Protein S100-A12 antagonist | ||
1 | Protein S100-A12 antagonists | Olopatadine |
Interacting Group | Interacting Drugs | |
---|---|---|
Amlexanox is a Protein S100-A13 antagonist | ||
1 | Protein S100-A13 ligands | Calcium citrate, Calcium Phosphate |
Interacting Group | Interacting Drugs | |
---|---|---|
Amlexanox is a Fibroblast growth factor 1 inhibitor | ||
1 | Fibroblast growth factor 1 antagonists | Pentosan polysulfate |
2 | Fibroblast growth factor 1 inhibitors | Pazopanib |
3 | Fibroblast growth factor 1 agonists | Foreskin fibroblast (neonatal), Foreskin keratinocyte (neonatal) |